Stephen W. Webster

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Steven P. Cobourn, as attorney-in-fact for Stephen W. Webster
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen W. Webster:

Form 4 holding Director

Gritstone bio, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$47,560
Report date
04 Apr 2025
Price
$1.90
Ownership
Direct
Form 4 holding Director

Nabriva Therapeutics plc

Security class
Ordinary Shares
Shares / value
11,447
Estimated value
$17,171
Report date
02 Aug 2022
Price
$1.50
Ownership
Direct
Form 4 holding Director

NextCure, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
18,700
Estimated value
Report date
20 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Gritstone bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
04 Apr 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

TCR2 THERAPEUTICS INC.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
01 Jun 2023
Price
$0.7400
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Stephen W. Webster

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .